معرفی
Luke A.J. O’Neill is a Professor (Chair of Biochemistry) at the School of Biochemistry and Immunology, Trinity College Dublin, Ireland. His academic career spans over three decades, with roles including Lecturer (1991-1999), Associate Professor (1999), Head of School (2005), and Founder Director of the Trinity Biomedical Sciences Institute (2011). He has held visiting positions at Millennium Pharmaceuticals (2004) and GlaxoSmithKline Ltd (2016).
Research Focus: Dr. O’Neill investigates the molecular and cellular mechanisms of inflammation and innate immunity, with emphasis on Toll-like receptors, signal transduction, immunometabolism, and metabolic reprogramming in immunity. His work bridges molecular biology with immunological disease analysis.
Scientific Contributions: He has published 285 peer-reviewed papers, 101 book chapters, and maintains an h-index of 145. His research has been recognized through prestigious awards including the
- Royal Irish Academy Gold Medal for Life Sciences (2012)
- European Federation of Immunology Societies Medal (2014)
- Landsteiner Award for biomedical sciences (2019)
- Listing in Clarivate's top 1% of immunologists (2018, 2019, 2022)
Commercial & Public Engagement: Co-founded biotech startups Inflazome Ltd (acquired by Roche) and Sitryx Ltd ($40m financing). He contributes to public science communication through a weekly radio show on Newstalk FM and authorship of two popular science books: Humanology (2018) and Never Mind the B*ll*cks, Here’s the Science (2020), the latter winning Ireland's Non-Fiction Book of the Year.
